Abstract
The hollow fiber assay (HFA) is a drug discovery tool to aid investigators in the prioritization of lead compounds identified by in vitro testing for further development in animal models of disease. In the HFA, cells are cultured in hollow fibers containing pores of a diameter (500 kDa) large enough for proteins and other macromolecules to enter, but too small for the cells to escape. The fibers are filled with cells, sealed and placed in the peritoneal cavity of immunodeficient mice. The mice undergo a predetermined treatment regimen after which the fibers are retrieved and the cells evaluated for activity of a target relevant to the disease modeled. The HFA combines advantages of both in vitro and in vivo assay systems. It uses the same cell lines used in culture systems, is a rapid assay, and requires fewer animals and less test substance than conventional xenograft systems. Like traditional in vivo assays, the test substance is evaluated in a live animal, which affords an initial assessment of associated toxicity and pharmacokinetic properties of the test substance.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hassan SB, de la Torre M, Nygren P, Karlsson MO, Larsson R, Jonsson E (2001) A hollow fiber model for in vitro studies of cytotoxic compounds: activity of the cyanoguanidine CHS 828. Anticancer Drugs 12:33–42
Hollingshead M, Roberson J, Decker W, Buckheit R Jr, Elder C, Malspeis L, Mayo J, Grever M (1995) In vivo drug screening applications of HIV-infected cells cultivated within hollow fibers in two physiologic compartments of mice. Antiviral Res 28:265–279
Hollingshead MG, Bonomi CA, Borgel SD, Carter JP, Shoemaker R, Melillo G, Sausville EA (2004) A potential role for imaging technology in anticancer efficacy evaluations. Eur J Cancer 40:890–898
Mi Q, Pezzuto JM, Farnsworth NR, Wani MC, Kinghorn AD, Swanson SM (2009) Use of the in vivo hollow fiber assay in natural products anticancer drug discovery. J Nat Prod 72:573–580
Kinghorn AD, Chin YW, Swanson SM (2009) Discovery of natural product anticancer agents from biodiverse organisms. Curr Opin Drug Discov Devel 12:189–196
Hollingshead MG, Alley MC, Camalier RF, Abbott BJ, Mayo JG, Malspeis L, Grever MR (1995) In vivo cultivation of tumor cells in hollow fibers. Life Sci 57:131–141
Davis J (2011) Animal cell culture: essential methods. Wiley, Hoboken
Freshney RI (2010) Culture of animal cells: a manual of basic technique and specialized applications, 6th edn. Wiley-Liss, Hoboken
Strober W (1997) Trypan blue exclusion test of cell viability. Curr Protoc Immunol, A.3B.1–A.3B.2
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A, Boyd MR (1991) Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res 51:2515–2520
Decker S, Hollingshead M, Bonomi CA, Carter JP, Sausville EA (2004) The hollow fibre model in cancer drug screening: the NCI experience. Eur J Cancer 40:821–826
Developmental Therapeutics Program, US National Cancer Institute. http://dtp.nci.nih.gov/dtpstandard/dwindex/index.jsp. Accessed July 28, 2012.
Shnyder SD, Hasan J, Cooper PA, Pilarinou E, Jubb E, Jayson GC, Bibby MC (2005) Development of a modified hollow fibre assay for studying agents targeting the tumour neovasculature. Anticancer Res 25:1889–1894
Developmental Therapeutics Program, US National Cancer Institute. http://dtp.nci.nih.gov/branches/btb/acute_tox.html. Accessed July 28, 2012.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Pearce, C.J. et al. (2012). Use of the Hollow Fiber Assay for the Discovery of Novel Anticancer Agents from Fungi. In: Keller, N., Turner, G. (eds) Fungal Secondary Metabolism. Methods in Molecular Biology, vol 944. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-122-6_20
Download citation
DOI: https://doi.org/10.1007/978-1-62703-122-6_20
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-121-9
Online ISBN: 978-1-62703-122-6
eBook Packages: Springer Protocols